All News
Prenatal PFAS Exposure and BP; EARLY TAVR Objections; Lorundrostat Win in HTN-CKD
(MedPage Today) -- Prenatal exposure to PFAS, known as "forever chemicals," was linked to higher blood pressure (BP) during adolescence in a cohort study.
Read MoreOpinion: Bill Gates: I lost my father to Alzheimer’s. But I’m more optimistic than ever about fighting the disease
Bill Gates writes: “We are on the cusp of turning the tide against dementia — which makes this an especially bad time to pull back on research.
Read MoreWhat the MAHA Report Gets Right, and Wrong, on Nutrition
(MedPage Today) -- In May, the Make America Healthy Again (MAHA) Commission released the much-anticipated MAHA Report.
Read MoreWhat is metabolic syndrome – and do we really need to worry about it?
Metabolic syndrome – popularized by two architects of Maha – is a real health issue, but messaging can take a turn toward scienceploitationMetabolic syndrome is trending online.
Read MoreSTAT+: FDA announces a new priority review program in bid to further administration goals
The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions align with the FDA's national health priorities.
Read MoreWhat to Put in a Travel First-Aid Kit: Key Items to Include
Experts weigh in on what to bring for a healthy, stress-free trip.
Read MoreWhat's Next in Myeloma: Trispecifics, Sequencing, and Precision Targeting
(MedPage Today) -- The American Society of Clinical Oncology (ASCO) meeting featured major updates in multiple myeloma, including early data on trispecific antibodies and novel bispecific combination
Read MoreSweaty and flustered, my breast cancer patient was experiencing hot flushes. The lack of good treatment is frustrating | Ranjana Srivastava
Anti-oestrogen medication is the penicillin of oncology, but not enough attention is paid to the living horror that many patients experience as a side-effect“Doctor, stop!” she abruptly commands m
Read MoreKraft Heinz pulling artificial dyes from its U.S. products in 2027
Kraft Heinz will be pulling artificial dyes from its U.S. products starting in 2027 and will no longer roll out new products with the dyes.
Read MorePrimary Care: The Next Generation
(MedPage Today) -- This week the new interns arrived to start their first year of residency training.
Read More